Angiotensin II reduces calcium uptake into bone

Pediatric Nephrology

Volumn 19, Issue 1, 2004, Pages 33-35

  Schurman, Scott J ^a   Bergstrom, William H ^a   Shoemaker, Lawrence R ^b   Welch, Thomas R ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Angiotensin II; Bartter syndrome; Basic fibroblast growth factor; Bone

Indexed keywords

ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; BUFFER; CALCIUM; GLYCOSAMINOGLYCAN; INDOMETACIN; MONOCLONAL ANTIBODY; PROSTAGLANDIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BARTTER SYNDROME; BIOASSAY; CALCIUM BONE LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HYPERCALCIURIA; KIDNEY CALCIFICATION; NEWBORN; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BARTTER SYNDROME; BONE AND BONES; CALCIUM; CELLS, CULTURED; HUMANS; RATS;

EID: 0347268940     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1361-4     Document Type: Article

References (16)

1. Schurman SJ, Shoemaker LR (2000) Bartter and Gitelman syndromes. Adv Pediatr 47:223-248
2. Proesmans W (1997) Barrier syndrome and its neonatal variant. Eur J Pediatr 156:669-679
3. Shoemaker LR, Bergstrom WH, Ragosta K, Welch TR (1998) Humoral factor in children with neonatal Banter syndrome reduces bone calcium uptake in vitro. Pediatr Nephrol 12:371-376
4. Williams WJ, Shoemaker LR, Schurman SJ, Welch TR, Bergstrom WH (1999) Conjunctive effects of fibroblast growth factor and glycosaminoglycan on bone metabolism in neonatal Bartter syndrome. Pediatr Res 45:726-732
5. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC (1962) Hyperplasia of juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 33:811-828
6. Peifly KA, Winkles JA (1998) Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem Biophys Res Commun 242:202-208
7. Cheek DB, West CD (1955) An appraisal of methods of tissue chloride analysis: the total carcass chloride, exchangeable chloride, potassium and water of the rat. J Clin Invest 34:1744-1755
8. Rovetto CR de, Welch TR, Hug G, Clark KE, Bergstrom W (1989) Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 115:397-404
9. Shoemaker L, Welch TR, Bergstrom W, Abrams SA, Yergey AL, Vieira N (1993) Calcium kinetics in the hyperprostaglandin E syndrome. Pediatr Res 33:92-96
10. Kawaguchi D, Chicazu K, Nadamura M, Kumegawa M, Hakeda Y (2000) Direct and indirect actions of fibroblast growth factor 2 on osteoclastic resorption in cultures. J Bone Miner Res 15:466-473
11. Lamparter S, Kling L, Schrader M, Zieglar R, Pfeilschrifter J (1998) Effects of angiotensin II on bone cells in vitro. J Cell Physiol 175:89-98
12. Hatton R, Stimpel M, Chambers TJ (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152:5-10
13. Zimering MB, Eng J (1996) Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 81:4446-4452
14. Pivonello R, Faggiano A, Di Somma C, Klain M, Filippella M, Salvatore M, Lombardi G, Colao A (1999) Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus. J Clin Endocrinol Metab 84:2349-2352
15. Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, Raisz LG, Hurley MM (1995) Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest 96:923-930
16. Shoemaker LR, Miller JJ, Pierce WM, Schurman SJ, Bergstrom WH (2000) Furosemide-induced hypercalciuria: a model of hypercalciuric Bartter syndrome. Pediatr Res 47:451A